DCGI gives nod for phase 2/3 trials of Biological E's Covid vaccine on those aged between 5 & 18

The phase 2 and 3 clinical trials have be conducted as per approved protocol titled 'A Prospective, Randomised, Double-blind, Placebo controlled, Phase-2/3 Study to Evaluate Safety, Reactogenicity, Tolerability and Immunogenicity of Corbevax Vaccine in Children and Adolescents', a source said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3zCRrks
via IFTTT